Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes

References

• Knowles N, Hovi T, Hyypiä T. Picornaviridae. In: Virus Taxonomy: Classification and Nomenclature of Viruses: Ninth Report of the International Committee on Taxonomy of Viruses. San Diego: King, A.M.Q., Adams, M.J., Carstens, E.B. and Lefkowitz, E.J; 2012. page 855-80.
   Google Scholar
• Tapparel C, Siegrist F, Petty TJ, Kaiser L. Picornavirus and enterovirus diversity with associated human diseases. Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis 2013; 14:282-93; http://dx.doi.org/10.1016/j.meegid.2012.10.016
   PubMed Web of Science ®Google Scholar
• Romero JR. Pediatric group B coxsackievirus infections. Curr Top Microbiol Immunol 2008; 323:223-39; PMID:18357772
   PubMed Web of Science ®Google Scholar
• Hober D, Alidjinou EK. Enteroviral pathogenesis of type 1 diabetes: queries and answers. Curr Opin Infect Dis 2013; 26:263-9; PMID:23549392; http://dx.doi.org/10.1097/QCO.0b013e3283608300
   PubMed Web of Science ®Google Scholar
• Hober D, Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 2010; 6:279-89; PMID:20351698; http://dx.doi.org/10.1038/nrendo.2010.27
   PubMed Web of Science ®Google Scholar
• Dotta F, Censini S, van Halteren AGS, Marselli L, Masini M, Dionisi S, Mosca F, Boggi U, Muda AO, Del Prato S, et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A 2007; 104:5115-20; PMID:17360338; http://dx.doi.org/10.1073/pnas.0700442104
   PubMed Web of Science ®Google Scholar
• Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 2009; 52:1143-51; PMID:19266182; http://dx.doi.org/10.1007/s00125-009-1276-0
   PubMed Web of Science ®Google Scholar
• Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Immunohistochemical analysis of the relationship between islet cell proliferation and the production of the enteroviral capsid protein, VP1, in the islets of patients with recent-onset type 1 diabetes. Diabetologia 2011; 54:2417-20; PMID:21597997; http://dx.doi.org/10.1007/s00125-011-2192-7
   PubMed Web of Science ®Google Scholar
• Ylipaasto P, Klingel K, Lindberg AM, Otonkoski T, Kandolf R, Hovi T, Roivainen M. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 2004; 47:225-39; PMID:14727023; http://dx.doi.org/10.1007/s00125-003-1297-z
   PubMed Web of Science ®Google Scholar
• Oikarinen M, Tauriainen S, Honkanen T, Vuori K, Karhunen P, Vasama-Nolvi C, Oikarinen S, Verbeke C, Blair GE, Rantala I, et al. Analysis of pancreas tissue in a child positive for islet cell antibodies. Diabetologia 2008; 51:1796-802; PMID:18696046; http://dx.doi.org/10.1007/s00125-008-1107-8
   PubMed Web of Science ®Google Scholar
• Spagnuolo I, Patti A, Sebastiani G, Nigi L, Dotta F. The case for virus-induced type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 2013; 20:292-8; PMID:23743646; http://dx.doi.org/10.1097/MED.0b013e328362a7d7
   PubMed Web of Science ®Google Scholar
• Richardson SJ, Leete P, Bone AJ, Foulis AK, Morgan NG. Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia 2013; 56:185-93; PMID:23064357; http://dx.doi.org/10.1007/s00125-012-2745-4
   PubMed Web of Science ®Google Scholar
• Foulis AK, Farquharson MA, Cameron SO, McGill M, Schönke H, Kandolf R. A search for the presence of the enteroviral capsid protein VP1 in pancreases of patients with type 1 (insulin-dependent) diabetes and pancreases and hearts of infants who died of coxsackieviral myocarditis. Diabetologia 1990; 33:290-8; PMID:2376300; http://dx.doi.org/10.1007/BF00403323
   PubMed Web of Science ®Google Scholar
• Foulis AK, McGill M, Farquharson MA, Hilton DA. A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM. Diabetologia 1997; 40:53-61; PMID:9028718; http://dx.doi.org/10.1007/s001250050642
   PubMed Web of Science ®Google Scholar
• Anagandula M, Richardson SJ, Oberste MS, Sioofy-Khojine A-B, Hyöty H, Morgan NG, Korsgren O, Frisk G. Infection of human islets of langerhans with two strains of Coxsackie B virus serotype 1: assessment of virus replication, degree of cell death and induction of genes involved in the innate immunity pathway. J Med Virol 2014; 86:1402-11; PMID:24249667; http://dx.doi.org/10.1002/jmv.23835
   PubMed Web of Science ®Google Scholar
• Elshebani A, Olsson A, Westman J, Tuvemo T, Korsgren O, Frisk G. Effects on isolated human pancreatic islet cells after infection with strains of enterovirus isolated at clinical presentation of type 1 diabetes. Virus Res 2007; 124:193-203; PMID:17169456; http://dx.doi.org/10.1016/j.virusres.2006.11.004
   PubMed Web of Science ®Google Scholar
• Hodik M, Lukinius A, Korsgren O, Frisk G. Tropism analysis of two coxsackie B5 strains reveals virus growth in human primary pancreatic islets but not in exocrine cell clusters In Vitro. Open Virol J 2013; 7:49-56; PMID:23723955; http://dx.doi.org/10.2174/1874357901307010049
   PubMedGoogle Scholar
• Pinkert S, Klingel K, Lindig V, Dörner A, Zeichhardt H, Spiller OB, Fechner H. Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line. J Virol 2011; 85:13409-19; PMID:21976640; http://dx.doi.org/10.1128/JVI.00621-11
   PubMed Web of Science ®Google Scholar
• Jaïdane H, Hober D. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab 2008; 34:537-48; PMID:18951821; http://dx.doi.org/10.1016/j.diabet.2008.05.008
   PubMed Web of Science ®Google Scholar
• Jaïdane H, Sauter P, Sane F, Goffard A, Gharbi J, Hober D. Enteroviruses and type 1 diabetes: towards a better understanding of the relationship. Rev Med Virol 2010; 20:265-80; PMID:20629044; http://dx.doi.org/10.1002/rmv.647
   PubMed Web of Science ®Google Scholar
• Chehadeh W, Kerr-Conte J, Pattou F, Alm G, Lefebvre J, Wattré P, Hober D. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol 2000; 74:10153-64; PMID:11024144; http://dx.doi.org/10.1128/JVI.74.21.10153-10164.2000
   PubMed Web of Science ®Google Scholar
• Yin H, Berg A-K, Westman J, Hellerström C, Frisk G. Complete nucleotide sequence of a Coxsackievirus B-4 strain capable of establishing persistent infection in human pancreatic islet cells: effects on insulin release, proinsulin synthesis, and cell morphology. J Med Virol 2002; 68:544-57; PMID:12376963; http://dx.doi.org/10.1002/jmv.10236
   PubMed Web of Science ®Google Scholar
• Sane F, Caloone D, Gmyr V, Engelmann I, Belaich S, Kerr-Conte J, Pattou F, Desailloud R, Hober D. Coxsackievirus B4 can infect human pancreas ductal cells and persist in ductal-like cell cultures which results in inhibition of Pdx1 expression and disturbed formation of islet-like cell aggregates. Cell Mol Life Sci CMLS 2013; 70:4169-80; PMID:23775130; http://dx.doi.org/10.1007/s00018-013-1383-4
   PubMed Web of Science ®Google Scholar
• Frisk G. Mechanisms of chronic enteroviral persistence in tissue. Curr Opin Infect Dis 2001; 14:251-6; PMID:11964840; http://dx.doi.org/10.1097/00001432-200106000-00002
   PubMed Web of Science ®Google Scholar
• Heim A, Canu A, Kirschner P, Simon T, Mall G, Hofschneider PH, Kandolf R. Synergistic interaction of interferon-beta and interferon-gamma in coxsackievirus B3-infected carrier cultures of human myocardial fibroblasts. J Infect Dis 1992; 166:958-65; PMID:1328409; http://dx.doi.org/10.1093/infdis/166.5.985
   PubMed Web of Science ®Google Scholar
• Heim A, Brehm C, Stille-Siegener M, Müller G, Hake S, Kandolf R, Figulla HR. Cultured human myocardial fibroblasts of pediatric origin: natural human interferon-alpha is more effective than recombinant interferon-alpha 2a in carrier-state coxsackievirus B3 replication. J Mol Cell Cardiol 1995; 27:2199-208; PMID:8576936; http://dx.doi.org/10.1016/S0022-2828(95)91515-X
   PubMed Web of Science ®Google Scholar
• Schmidtke M, Selinka HC, Heim A, Jahn B, Tonew M, Kandolf R, Stelzner A, Zell R. Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1. Virology 2000; 275:77-88; PMID:11017789; http://dx.doi.org/10.1006/viro.2000.0485
   PubMed Web of Science ®Google Scholar
• Chapman NM, Kim K-S, Drescher KM, Oka K, Tracy S. 5′ terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart. Virology 2008; 375:480-91; PMID:18378272; http://dx.doi.org/10.1016/j.virol.2008.02.030
   PubMed Web of Science ®Google Scholar
• Kim K-S, Tracy S, Tapprich W, Bailey J, Lee C-K, Kim K, Barry WH, Chapman NM. 5′-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J Virol 2005; 79:7024-41; PMID:15890942; http://dx.doi.org/10.1128/JVI.79.11.7024-7041.2005
   PubMed Web of Science ®Google Scholar
• Kim K-S, Chapman NM, Tracy S. Replication of coxsackievirus B3 in primary cell cultures generates novel viral genome deletions. J Virol 2008; 82:2033-7; PMID:18057248; http://dx.doi.org/10.1128/JVI.01774-07
   PubMed Web of Science ®Google Scholar
• Tracy S, Smithee S, Alhazmi A, Chapman N. Coxsackievirus can persist in murine pancreas by deletion of 5′ terminal genomic sequences. J Med Virol 2015; 87:240-7; PMID:25111164; http://dx.doi.org/10.1002/jmv.24039
   PubMed Web of Science ®Google Scholar
• Tam PE, Messner RP. Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J Virol 1999; 73:10113-21; PMID:10559326
   PubMed Web of Science ®Google Scholar
• Fechner H, Pinkert S, Wang X, Sipo I, Suckau L, Kurreck J, Dörner A, Sollerbrant K, Zeichhardt H, Grunert H-P, et al. Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor. Gene Ther 2007; 14:960-71; PMID:17377597; http://dx.doi.org/10.1038/sj.gt.3302948
   PubMed Web of Science ®Google Scholar
• Werk D, Schubert S, Lindig V, Grunert H-P, Zeichhardt H, Erdmann VA, Kurreck J. Developing an effective RNA interference strategy against a plus-strand RNA virus: silencing of coxsackievirus B3 and its cognate coxsackievirus-adenovirus receptor. Biol Chem 2005; 386:857-63; PMID:16164410; http://dx.doi.org/10.1515/BC.2005.100
   PubMed Web of Science ®Google Scholar
• Feuer R, Whitton JL. Preferential coxsackievirus replication in proliferating/activated cells: implications for virus tropism, persistence, and pathogenesis. Curr Top Microbiol Immunol 2008; 323:149-73; PMID:18357769
   PubMed Web of Science ®Google Scholar
• Feuer R, Mena I, Pagarigan R, Slifka MK, Whitton JL. Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J Virol 2002; 76:4430-40; PMID:11932410; http://dx.doi.org/10.1128/JVI.76.9.4430-4440.2002
   PubMed Web of Science ®Google Scholar
• Feuer R, Mena I, Pagarigan RR, Hassett DE, Whitton JL. Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency. Med Microbiol Immunol (Berl) 2004; 193:83-90; ; http://dx.doi.org/10.1007/s00430-003-0192-z
   PubMed Web of Science ®Google Scholar
• Grey F. Role of microRNAs in herpesvirus latency and persistence. J Gen Virol 2015; 96:739-51; PMID:25406174; http://dx.doi.org/10.1099/vir.0.070862-0
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-33; PMID:19167326; http://dx.doi.org/10.1016/j.cell.2009.01.002
   PubMed Web of Science ®Google Scholar
• Hammond SM. An overview of microRNAs. Adv Drug Deliv Rev 2015; 87:3-14; PMID:25979468; http://dx.doi.org/10.1016/j.addr.2015.05.001
   PubMed Web of Science ®Google Scholar
• El-Diwany R, Wasilewski LN, Witwer KW, Bailey JR, Page K, Ray SC, Cox AL, Thomas DL, Balagopal A. Acute hepatitis C virus infection induces consistent changes in circulating microRNAs that are associated with nonlytic hepatocyte release. J Virol 2015; 89:9454-64; PMID:26157120; http://dx.doi.org/10.1128/JVI.00955-15
   PubMed Web of Science ®Google Scholar
• Kim H, Choi H, Lee SK. Epstein-Barr Virus MicroRNA miR-BART20-5p Suppresses Lytic Induction by Inhibiting BAD-Mediated caspase-3-Dependent Apoptosis. J Virol 2016; 90:1359-68; http://dx.doi.org/10.1128/JVI.02794-15
   Web of Science ®Google Scholar
• Ho B-C, Yang P-C, Yu S-L. MicroRNA and Pathogenesis of Enterovirus Infection. Viruses 2016; 8:E11; http://dx.doi.org/10.3390/v8010011
   PubMed Web of Science ®Google Scholar
• Alidjinou EK, Sané F, Bertin A, Caloone D, Hober D. Persistent infection of human pancreatic cells with Coxsackievirus B4 is cured by fluoxetine. Antiviral Res 2015; 116:51-4; PMID:25655448; http://dx.doi.org/10.1016/j.antiviral.2015.01.010
   PubMed Web of Science ®Google Scholar
• Ho B-C, Yu S-L, Chen JJW, Chang S-Y, Yan B-S, Hong Q-S, Singh S, Kao C-L, Chen H-Y, Su K-Y, et al. Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell Host Microbe 2011; 9:58-69; PMID:21238947; http://dx.doi.org/10.1016/j.chom.2010.12.001
   PubMed Web of Science ®Google Scholar
• Tong L, Lin L, Wu S, Guo Z, Wang T, Qin Y, Wang R, Zhong X, Wu X, Wang Y, et al. MiR-10a* up-regulates coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence. Nucleic Acids Res 2013; 41:3760-71; PMID:23389951; http://dx.doi.org/10.1093/nar/gkt058
   PubMed Web of Science ®Google Scholar
• Wen B, Dai H, Yang Y, Zhuang Y, Sheng R. MicroRNA-23b inhibits enterovirus 71 replication through downregulation of EV71 VPl protein. Intervirology 2013; 56:195-200; PMID:23594713; http://dx.doi.org/10.1159/000348504
   PubMed Web of Science ®Google Scholar
• Zhang Q, Xiao Z, He F, Zou J, Wu S, Liu Z. MicroRNAs regulate the pathogenesis of CVB3-induced viral myocarditis. Intervirology 2013; 56:104-13; PMID:23183417; http://dx.doi.org/10.1159/000343750
   PubMed Web of Science ®Google Scholar
• Organtini LJ, Makhov AM, Conway JF, Hafenstein S, Carson SD. Kinetic and structural analysis of coxsackievirus B3 receptor interactions and formation of the A-particle. J Virol 2014; 88:5755-65; PMID:24623425; http://dx.doi.org/10.1128/JVI.00299-14
   PubMed Web of Science ®Google Scholar
• Lysy PA, Weir GC, Bonner-Weir S. Making β cells from adult cells within the pancreas. Curr Diab Rep 2013; 13:695-703; PMID:23925431; http://dx.doi.org/10.1007/s11892-013-0400-1
   PubMed Web of Science ®Google Scholar
• Dörner A, Xiong D, Couch K, Yajima T, Knowlton KU. Alternatively spliced soluble coxsackie-adenovirus receptors inhibit coxsackievirus infection. J Biol Chem 2004; 279:18497-503; PMID:14978041; http://dx.doi.org/10.1074/jbc.M311754200
   PubMed Web of Science ®Google Scholar
• Thoelen I, Magnusson C, Tågerud S, Polacek C, Lindberg M, Van Ranst M. Identification of alternative splice products encoded by the human coxsackie-adenovirus receptor gene. Biochem Biophys Res Commun 2001; 287:216-22; PMID:11549277; http://dx.doi.org/10.1006/bbrc.2001.5535
   PubMed Web of Science ®Google Scholar
• Kim KW, Ho A, Alshabee-Akil A, Hardikar AA, Kay TWH, Rawlinson WD, Craig ME. Coxsackievirus B5 Infection Induces Dysregulation of microRNAs Predicted to Target Known Type 1 Diabetes Risk Genes in Human Pancreatic Islets. Diabetes 2016; 65:996-1003; PMID:26558682; http://dx.doi.org/10.2337/db15-0956
   PubMed Web of Science ®Google Scholar
• Beaulieux F, Zreik Y, Deleage C, Sauvinet V, Legay V, Giraudon P, Kean KM, Lina B. Cumulative mutations in the genome of Echovirus 6 during establishment of a chronic infection in precursors of glial cells. Virus Genes 2005; 30:103-12; PMID:15744568; http://dx.doi.org/10.1007/s11262-004-4587-8
   PubMed Web of Science ®Google Scholar
• Duncan G, Colbère-Garapin F. Two determinants in the capsid of a persistent type 3 poliovirus exert different effects on mutant virus uncoating. J Gen Virol 1999; 80 (Pt 10):2601-5; PMID:10573152; http://dx.doi.org/10.1099/0022-1317-80-10-2601
   PubMed Web of Science ®Google Scholar
• Duncan G, Pelletier I, Colbère-Garapin F. Two amino acid substitutions in the type 3 poliovirus capsid contribute to the establishment of persistent infection in HEp-2c cells by modifying virus-receptor interactions. Virology 1998; 241:14-29; PMID:9454713; http://dx.doi.org/10.1006/viro.1997.8955
   PubMed Web of Science ®Google Scholar
• Pelletier I, Duncan G, Pavio N, Colbère-Garapin F. Molecular mechanisms of poliovirus persistence: key role of capsid determinants during the establishment phase. Cell Mol Life Sci CMLS 1998; 54:1385-402; PMID:9893712; http://dx.doi.org/10.1007/s000180050261
   PubMed Web of Science ®Google Scholar
• Yoon JW, Austin M, Onodera T, Notkins AL. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979; 300:1173-9; PMID:219345; http://dx.doi.org/10.1056/NEJM197905243002102
   PubMed Web of Science ®Google Scholar
• Alidjinou EK, Sané F, Engelmann I, Hober D. Serum-dependent enhancement of coxsackievirus B4-induced production of IFNα, IL-6 and TNFα by peripheral blood mononuclear cells. J Mol Biol 2013; 425:5020-31; PMID:24120940; http://dx.doi.org/10.1016/j.jmb.2013.10.008
   PubMed Web of Science ®Google Scholar
• Lam WY, Cheung ACY, Tung CKC, Yeung ACM, Ngai KLK, Lui VWY, Chan PKS, Tsui SKW. miR-466 is putative negative regulator of Coxsackie virus and Adenovirus Receptor. FEBS Lett 2015; 589:246-54; PMID:25497012; http://dx.doi.org/10.1016/j.febslet.2014.12.006
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods San Diego Calif 2001; 25:402-8; http://dx.doi.org/10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Chen C-J, Servant N, Toedling J, Sarazin A, Marchais A, Duvernois-Berthet E, Cognat V, Colot V, Voinnet O, Heard E, et al. ncPRO-seq: a tool for annotation and profiling of ncRNAs in sRNA-seq data. Bioinforma Oxf Engl 2012; 28:3147-9; http://dx.doi.org/10.1093/bioinformatics/bts587
   PubMed Web of Science ®Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014; 15:550; PMID:25516281; http://dx.doi.org/10.1186/s13059-014-0550-8
   PubMed Web of Science ®Google Scholar